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Abstract: AIM To assess mid-term clinical, radiographic and profilometric outcomes at implant sites,
previously grafted with a volume-stable collagen matrix (VCMX) or an autogenous subepithelial connec-
tive tissue graft (SCTG). METHODS VCMX or SCTG were randomly applied to single implant sites
in 20 patients. Following abutment connection and insertion of final reconstructions (baseline), patients
were re-examined at 6 months (6M), at 1 year (FU-1) and at 3 years (FU-3). Measurements included
the following: clinical data, radiographic measurement of first bone to implant contact (fBIC), soft tissue
thickness and volumetric outcomes. Non-parametric tests and estimates were applied for the statistical
analysis. RESULTS The median buccal mucosal thickness increased by 0.5 mm (Q1: -0.5; Q3: 1.25)
(VCMX) (p = .281) and by 0.8 mm (Q1: 0.0; Q3: 2.5) (SCTG) (p = .047) between BL and FU-3 (in-
tergroup p = .303). The profilometric changes of the buccal soft tissues demonstrated a median decrease
between BL and FU-3 of -0.2 mm (Q1: -0.5; Q3: -0.1) (p = .039) for VCMX and a decrease of -0.1 mm
(Q1: -0.8; Q3: 0.1) (p = .020) for SCTG, respectively (intergroup p = .596). Peri-implant soft tissues and
bone levels remained healthy throughout the entire study period. PROMs did not show any significant
differences between the groups nor significant changes over time. CONCLUSION Minimal changes of the
peri-implant tissue contour as well as of the soft tissue thickness were observed at implant sites previously
grafted with VCMX or SCTG.
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CLINICAL RELEVANCE
Scientific rationale for the study: Soft grafting procedures to augment mucosal thickness are 
often performed at implant sites to enhance esthetics and peri-implant health. Limited mid-
term data following crown insertion is available for implant sites having been grafted with 
autogenous grafts (SCTG) or a volume-stable collagen matrix (VCMX). 
Principal findings: Implant sites grafted with VCMXs or SCTGs demonstrated minimal 
changes of the buccal tissue volume, stable marginal bone levels and peri-implant health 3 
years after insertion of final reconstructions without relevant differences between the two 
groups. 
Practical implications: After insertion of final reconstructions, implant sites previously 
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ABSTRACT
Aim: To assess mid-term clinical, radiographic and profilometric outcomes at implant sites, 
previously grafted with a volume-stable collagen matrix (VCMX) or an autogenous 
subepithelial connective tissue graft (SCTG). 
Methods: VCMX or SCTG were randomly applied to single implant sites in 20 patients. 
Following abutment connection and insertion of final reconstructions (baseline), patients 
were re-examined at 6 months (6M), at 1 year (FU-1) and at 3 years (FU-3). Measurements 
included: clinical data, radiographic measurement of first bone to implant contact (fBIC), soft 
tissue thickness and volumetric outcomes. Nonparametric tests and estimates were applied 
for the statistical analysis.
Results: The median buccal mucosal thickness decreased by -0.5mm (Q1:0.5;Q3:-
1.25)(VCMX)(p=0.281) and by -0.75mm (Q1:0.0;Q3:-2.5)(SCTG)(p=0.047) between BL and 
FU-3 (intergroup p=0.303). The profilometric changes of the buccal soft tissues 
demonstrated a median decrease between BL and FU-3 of -0.2mm (Q1:-0.5;Q3:-
0.1)(p=0.039) for VCMX and a decrease of -0.1mm (Q1:-0.8;Q3:0.1)(p=0.020) for SCTG 
respectively (intergroup p=0.596). Peri-implant soft tissues and bone levels remained 
healthy throughout the entire study period. PROMs did not show any significant differences 
between the groups nor significant changes over time.
Conclusion: Minimal changes of the peri-implant tissue contour as well as of the soft tissue 
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INTRODUCTION
Soft tissue augmentation therapy is indicated in partially and fully edentulous patients to 
increase the mucosal/gingival thickness around dental implants and teeth in conjunction with 
dental reconstructions (Schneider et al., 2011). These procedures applying autogenous 
subepithelial connective tissue grafts (SCTG) represent the current gold standard to 
surgically correct localized alveolar defects as pre-prosthetic site development and to 
enhance biological and esthetic outcomes at implant sites (Thoma et al., 2009, Thoma et al., 
2014, Sculean et al., 2019, Roccuzzo et al., 2017, Bouri et al., 2008, Thoma et al., 2018, 
Giannobile et al., 2018). 
Research has focused on the development and preclinical as well as clinical assessment of 
various soft tissue substitutes serving as replacements for autogenous grafts (Thoma et al., 
2010, Lorenzo et al., 2012, Zeltner et al., 2017, Thoma et al., 2016). This is based on the 
fact that the use of soft tissue substitutes results in a reduced patient morbidity and a 
shorter surgery time. A plethora of materials was evaluated in the past 20 years, 
predominantly of allogenic or xenogeneic origin (Wolff et al., 2016). Gain in mucosal or 
gingival thickness, applying these soft tissue substitutes, appears to be challenging to obtain 
as well as to maintain. More recently, a volume-stable collagen matrix (VCMX) rendered a 
volume gain non-inferior to SCTGs at implant sites as assessed by transmucosal probing and 
profilometric outcomes (Zeltner et al., 2017). The outcomes of the study are limited by the 
fact that the observation period represented the initial healing phase of 3 months post-
surgery. Thereafter, abutment connection was performed, followed by the placement of final 
implant-borne reconstructions. This resulted in a number of confounding factors associated 
with varying diameters and shapes of healing abutments as well as differences in terms of 
the emergence profile between the sites. No mid-term data for soft tissue substitutes having 
been applied at implant sites were reported so far.
The aim of the present study was, therefore, to assess clinical, radiographic and profilometric 




The present study was designed as a non-interventional follow-up of patients previously 
enrolled in a randomized controlled clinical study performed according to ISO Standard 
14155:2011, Clinical Investigation of medical devices for human patients with appendices 
VIII and X of the Medical Device Directive 93/42EFC and Declaration of Helsinki, 2004 
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2012-0226) and performed at the Clinic of Reconstructive Dentistry in Zürich between 
November 2015 and March 2018. The reporting of the present study follows the guidelines of 
the CONSORT statement (http://www.consort-statement.org/). 
INCLUSION CRITERIA
Specific inclusion criteria involved:
1. Patients previously enrolled in an RCT (Thoma et al., 2016) and a follow-up study (Huber 
et al., 2018) were re-examined three years post insertion of final reconstructions. 
2. Final restoration inserted at the implant site
3. Ability to fully understand the nature of the proposed non-interventional long-term follow-
up study and the ability to sign the informed consent form
EXCLUSION CRITERIA:
1. Newly developed disease interfering with soft tissue regeneration (e.g. diabetes)
2. Peri-implant infection (not related to previously performed soft tissue regeneration) 
following the insertion of the final reconstruction
3. Second soft tissue augmentation since completion of study (Thoma et al., 2016)
4. Severe trauma to implant site
5. Orthodontic treatment in the same quadrant
6. Patients not willing to participate in the 3-year follow-up examination.
CLINICAL PROCEDURES
In all 20 patients originally included in a RCT (Thoma et al., 2016) a soft tissue grafting 
procedure was performed at a single-tooth implant site (submerged healing). In brief, 
following local anaesthesia, sulcular incision was made around the neighbouring teeth of a 
single tooth gap. Subsequently, a straight crestal or slightly palatal/lingual horizontal incision 
was performed to connect the mesial and distal line angles. A split-thickness flap was 
elevated on the buccal side. A pouch was then prepared exceeding the space needed for the 
transplant. Thereafter, a sealed envelope was opened, containing the assignment for either 
one of two treatment modalities:
- cross-linked volume-stable collagen matrix (VCMX) (Geistlich Fibro-Gide®, Geistlich Pharma 
AG, Wolhusen, Switzerland) 
- autogenous subepithelial connective tissue graft (SCTG).
In group VCMX, the matrix with an initial dimension of 25mm x 25mm x 8mm was shaped 
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In group SCTG, following a single incision technique, an autogenous connective tissue graft 
was harvested at the palate. 
The graft was positioned into the pouch and sutured to the palatal flap. Primary tension-free 
wound closure was obtained with a horizontal mattress and single interrupted sutures (Gore 
Tex 5-0; W.L. Gore & Associates, Inc Flagstaff, Arizona, USA). Patients were instructed to 
rinse with 0.2 % chlorhexidine solution (Hibitan; Astra-Zeneca) and were prescribed with 
anti-inflammatory medications (Ponstan; Parke-Davis) and 2.25 g amoxiciline (Amoxicilline; 
Sandoz) per day for 7 days. Temporary removable partial dentures were adapted to avoid 
trauma to the surgical area. Suture removal was scheduled 7-10 days after surgery.
Three months later, abutment connection was performed, followed by the insertion of final 
fixed single-tooth reconstructions. Patients were then scheduled for a baseline examination 
and enrolled in an individual maintenance program.
BASELINE AND FOLLOW-UP EXAMINATIONS
Two weeks after insertion of final reconstructions, a baseline (BL) examination was 
performed. Further follow-up examinations took place at 6 months (6M), 1 year (FU-1) and 3 
years (FU-3). All follow-up examinations were performed by a blinded examiner, not involved 
in the previous RCT and thereby unaware of the treatment the patients had received. 
OUTCOME MEASURES
PRIMARY OUTCOME MEASURE: MUCOSAL THICKNESS
The mucosal thickness was measured using an endodontic file (K-File 31/15, Dentsply 
Maillefer, York, USA). The file was inserted 1mm apical of the mucosal margin on the buccal 
side of the implant crown. The change in mucosal thickness over time (BL to FU-3) was 
considered as primary outcome. Stability was considered as changes <0.5mm (Sapata et al., 
2018).
SECONDARY OUTCOME MEASURES
PROFILOMETRIC CHANGES OF THE PERI-IMPLANT TISSUES
Impressions of the implant sites and the two neighbouring teeth were taken using an A-
silicone impression material (President, Coltene/Whaledent, Alstätten, Switzerland). Casts 
were made out of dental stone and scanned to STL (stereolithography) files. The STL files 
were then imported into a digital imaging software program (SMOP, Swissmeda, Zurich, 
Switzerland). The ROI (region of interest) had a trapezoid shape and was defined as follows: 
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the mucogingival junction; the mesial and distal borders were at a distance of 1mm from the 
neighbouring teeth (Figure 1 A, B). The ROI varied between patients due to inter-individual 
anatomical differences between the sites. Once the ROI was defined in the first assessment, 
it had the same dimension at all assessment time-points. The STL data of the baseline 
models were superimposed with the follow-up models (6M, FU-1 and FU-3) by using the 
best-fit algorithm on the surfaces of the surrounding structures. The software then measured 
the mean distance between the surfaces (representing the time-points: BL, 6M, FU-1, FU-3) 
within the ROI in mm.
CLINICAL AND PERIODONTAL MEASUREMENTS
The following measurements were performed at the implant sites and the two neighbouring 
teeth: probing depth (PD), the plaque index (PI) (Loe and Silness, 1963), bleeding on 
probing (BOP), the width of keratinized tissue (KT) at the buccal aspect. All measurements 
(except the width of KT) were assessed at 6 sites at each implant site and the two adjacent 
teeth. 
RADIOLOGIC EXAMINATION AND ASSESSMENT OF BONE LOSS
Marginal bone loss was recorded by measuring the first bone to implant contact (fBIC) at the 
mesial and distal aspect of each implant at BL and after 3 years. FBIC was measured on peri-
apical radiographs taken with the long-cone paralleling technique and a software program 
(ImageJ 1.51; Wayne Rasband, National Institutes of Health, Bethesda, MD, USA). The 
implant length was used to calibrate the measurement. The reported fBIC length represents 
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ESTHETICS
The papilla fill was evaluated using the papilla index (Jemt, 1997). The papilla score was 
measured for each implant site and the contralateral tooth site on the mesial and distal 
aspect. The crown height was assessed by measuring the distance between the incisal edge 
and the most apical location of the mucosal margin on the buccal side. In addition, the Pink 
Esthetic Score (PES) (Furhauser et al., 2005) was recorded evaluating the peri-implant soft 
tissues and encompassing 7 parameters and scores from 0 (poorest) to 2 (best). The highest 
achievable score was 14.
PATIENT-REPORTED OUTCOME MEASURES (PROMS)
PROMs were assessed at each follow-up time-point by patients filling out a standardized 
questionnaire (oral health impact profile-G14; OHIP-G14).
RANDOMIZATION PROCEDURE, CONCEALMENT OF ALLOCATION AND OUTCOME ASSESSMENTS
In order to guarantee balance in patients allocated to either group, block randomization was 
used. Allocation concealment was performed by a study monitor, preparing the assignments 
in opaque, sealed envelopes. Group allocation was revealed during surgery after preparation 
of the recipient site. Due to the nature of the treatment, only the outcome assessment 
procedure could be blinded. Follow-up examinations were performed by a blinded examiner 
not involved in the surgical phase of the study. 
Statistical analysis 
Mean, median, standard deviation and the quartiles Q1 and Q3 were used to describe the 
continuously scaled variables (expressed as median (Q1;Q3) later on) and counts and 
percentages for categorically scaled variables. Nonparametric statistical methods were 
applied. The differences of the medians between the treatment groups were evaluated with 
the Mann-Whitney and within a treatment group with the Wilcoxon signed rank test. The 
treatment-related differences of medians are expressed as Hodges-Lehmann-estimates incl. 
the 95%-confidence intervals. The data were analyzed as intention-to-treat set (ITT: all 
randomized patients with post-baseline data). No relevant differences were found between 
the results in both analysis sets. The results for the primary objective are therefore 
presented as PP analysis set (ITT analysis is not generally conservative in non-inferiority 
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clinical trial, the sample size resulted out of the corresponding published study (Thoma et al., 
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RESULTS
VCMX was randomly applied to 10 patients (mean age 44.1 ± 12.8 years; 7 female and 3 
males) whereas the remaining 10 patients were treated with a SCTG (mean age 43.4 ± 18.8 
years, 6 female and 4 males). Table 1 displays an overview on patient demographics. A 
baseline examination was performed in all 20 patients between November 2012 and April 
2015. 
Out of the originally 20 patients entering the RCT, 17 attended the FU-3 examination 
between November 2015 and March 2018. Two patients (one for each group) died between 
FU-1 and FU-3. Another patient (group VCMX) relocated and did not attend any follow-up 
examination. The remaining 17 patients were included in the analysis (Fig. 2).
Mucosal thickness
The median mucosal thickness at baseline was 3.0mm (Q1 first quartile: 3.0; Q3 third 
quartile: 4.0) in group VCMX and 3.0mm (2.5;3.0) in group SCTG (intergroup comparison: p  
= 0.128). The respective figures at FU-3 were 3.5mm (3.0;4.0) (VCMX) and 3.3mm 
(3.0;5.5) (SCTG) (intergroup comparison: p = 0.901). The median changes in mucosal  
thickness were 0.5mm (-0.5;1.3) in group VCMX (p = 0.281). The respective numbers in 
group SCTG were 0.8mm (0.0;2.5) (p = 0.047). Intergroup comparisons over time and at 
any time-point were not statistically significantly different (Table 2). 
Profilometric changes of the peri-implant tissues
Between BL and FU-3 both groups demonstrated a significant median decrease in the soft 
tissue contour of -0.2mm (-0.5;-0.1) for VCMX (p = 0.039) and -0.1mm (-0.8;0.1) for SCTG 
respectively (p = 0.020). Between the two groups, no statistically significant differences 
were observed (Hodges-Lehmann estimation of difference: 
-0.05 p = 0.596). All data is displayed in Table 3. , 
Clinical and periodontal measurements
The peri-implant tissues were healthy at BL as well as at FU-3. Changes over time were 
minimal except for PD in group SCTG with a median increase between BL and FU-3 of 
0.50mm (0.28;0.67) (p = 0.004). Differences between VCMX and SCTG sites were not 
statistically significant for any of the outcomes measure (PI, BOP, PD, KT) at any time-point 
(p>0.05) (Appendix Table 1 A, B, C, D).
RADIOLOGIC EXAMINATION AND ASSESSMENT OF BONE LOSS
A statistically significant difference between treatment groups was observed at baseline for 
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Although a higher marginal bone loss was observed for VCMX after 3 years vs. baseline -
0.7mm (-1.5;-0.1) (p = 0.016) compared to SCTG -0.2mm (-0.4;-0.0) (p = 0.012), the 
difference in change of -0.679 (95%-CI: -1.36; 0.12mm) (Table 4) was not significant 
(intergroup p = 0.163).
Esthetics
Median PES scores were 9.0 (9.0;11.0) for VCMX and 8.5 (6.0;11.0) for SCTG at BL 
(intergroup p = 0.444). At FU-3, PES scores amounted to 8.5 (7.5;11.0) for VCMX and 10 
(9.0;10.0) for SCTG (intergroup p = 0.354) (Appendix Table 2). 
Patient-reported outcome measures
Median overall OHIP scores were 0 at BL, at 6M and at FU-1. The respective numbers at FU-
3, however, were significantly different between VCMX 0.5 (0.0;2.0) and SCTG 0.0 (0.0;0.0) 
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DISCUSSION
The present RCT, comparing a soft tissue substitute to an autogenous connective tissue graft 
for gain of mucosal thickness at single implant sites demonstrated in both groups between 
baseline (crown insertion) and the 3-year follow-up: i) a slight increase in mucosal thickness; 
ii) a slight decrease of the buccal peri-implant tissue contour; iii) healthy peri-implant tissues 
and stable esthetics.
Soft tissue grafting procedures are frequently performed at implant sites for esthetic and 
biological reasons (Hammerle and Tarnow, 2018, Chen and Buser, 2014). Previous studies 
predominantly focused on the initial healing period following the grafting procedure and did 
not follow-up the patient population over time. Dental implants and the respective 
reconstructions demonstrate high long-term survival rates (Pjetursson et al., 2014, Jung et 
al., 2012). This does, however, not take into account any biological or esthetic outcomes. 
From the patient’s and clinician’s perspective, healthy and stable peri-implant tissues as well 
as aesthetics are essential. The goal of grafting procedures for gain of mucosal thickness is 
an increase in the buccal contour predominantly for aesthetic purposes as well as to maintain 
peri-implant health. Recent evidence suggests that implant sites having been grafted with 
soft tissue substitutes or autogenous grafts result in more stable marginal bone levels and 
superior peri-implant health (Linkevicius et al., 2015, Giannobile et al., 2018, Linkevicius et 
al., 2009, Thoma et al., 2018).
Methods to analyze soft tissues over time include transmucosal probing (endodontic 
instruments), ultrasonic devices and non-invasive profilometric and volumetric 
measurements based on casts or optical scans (Huber et al., 2018, Windisch et al., 2007, 
Fickl et al., 2009, Thoma et al., 2016, Eghbali et al., 2016). In the present study, the soft 
tissues were assessed by transmucosal probing and demonstrated an increase in mucosal 
thickness over time by 0.5mm (VCMX) and 0.75mm (SCTG) respectively. Absolute values of 
the mucosal thickness were >3mm at all time-points indicating that at implant sites, more 
soft tissue is present compared to natural teeth. In a recent RCT, a non-cross-linked collagen 
matrix (CM) was compared to a 1mm thick, palatally harvested SCTG for gain of mucosal 
thickness at the time of abutment connection (Cairo et al., 2017). Transmucosal probing at 3 
months yielded a thickness of 2.8mm (±0.7) for the CM group and 3.1mm (±0.5) for the 
SCTG group. At 6 months, a thickness of 3.0mm (±0.7) for the CM and 3.4mm (±0.6) for 
the SCTG group was measured. The study concluded that the use of an autogenous graft 
(SCTG) led to a higher increase of soft tissue thickness than CM (0.3mm higher mean values 
for SCTG). The obtained data for the final mucosal thickness is in line with the present study, 
revealing a mean soft tissue thickness of 2.94 (VCMX) and 2.95 (SCTG) at 6 months. The 
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one study (Thoma et al., 2016), the soft tissue grafting procedure was performed prior to 
abutment connection, whereas in the second study, the mucosal thickness was increased in 
conjunction with abutment connection (Cairo et al., 2017). Interestingly, over time (up to 6 
months), both studies revealed a stable mucosal thickness or even a slight gain. 
Apart from measuring the mucosal thickness, changes of the buccal contour are a relevant 
outcome measure. This method is capable of measuring changes in the buccal contour 
between different time-points. Data over 3 years indicated an overall slight loss of the buccal 
contour between 0.2mm (VCMX) and 0.13mm (SCTG) in the present study. Changes of the 
buccal contour can be based on a loss of soft tissue, a loss of hard tissue or a combined loss 
of hard and soft tissue. At 3 years post-insertion of final reconstructions, the overall mucosal 
thickness in the present study was higher compared to all previous follow-up examinations. 
Without having cone-beam computed tomographies (CBCTs), one can only speculate that the 
increase in mucosal thickness (as assessed by transmucosal probing) was accompanied by 
ongoing changes of the hard tissues on the buccal side of the implants, since the buccal 
contour slightly decreased. In a RCT comparing facial augmentation by means of SCTG or 
GBR, measurements were performed by superimposition of CBCTs at three different time-
points (before surgery, 2 weeks after surgery and at the 1-year follow-up) (De Bruyckere et 
al., 2018). The mean gain of volume (mean absolute buccal soft tissue profile gain) after one 
year of healing time was similar: 0.94mm in the GBR group and 0.81mm in the SCTG group. 
In the SCTG group, a mean of 0.8mm was lost, compared to a mean loss of 1.59mm in the 
GBR group. The GBR group resulted in a higher absolute buccal soft tissue profile gain two 
weeks after surgery, due to limited dimensions of the SCTG and to significantly more 
oedema in the early stages of healing caused by higher invasiveness of the GBR procedure. 
This was followed by a significantly higher shrinkage rate in the GBR group. 
Apart from improving aesthetics, soft tissue grafting procedures were also proposed to 
maintain peri-implant health and to minimize loss of marginal bone (Lin and Madi, 2019, 
Thoma et al., 2018). Without a control group (receiving no soft tissue grafting procedure), 
the beneficial effect of the surgical intervention can not be assessed in the present study. 
Based on clinical studies and systematic reviews, the soft tissue thickness and quality seems, 
however, to play an important role in maintaining or improving peri-implant health (Akcali et 
al., 2017, Sculean et al., 2019, Roccuzzo et al., 2017, Thoma et al., 2018, Furhauser et al., 
2005). Whereas bleeding indices (a key factor to assess peri-implant health) do not appear 
to be influenced by a grafting procedure for gain of mucosal thickness, data from a 
systematic review indicated significantly less marginal bone loss over time and a borderline 
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indicate the beneficial biological effect of grafting procedures for gain of mucosal thickness at 
implant sites. In the present study, peri-implant tissues were and remained healthy in both 
treatment groups. This was documented by stable BOP and PD values. Even though from a 
statistical point of view, in group SCTG, PD values increased significantly, the change of 
0.5mm might be clinically negligible.
One of the greatest benefits of using soft tissue substitutes is decreased patient morbidity. 
This was successfully documented in the previously published 3-month data RCT (Thoma et 
al., 2016) when PROMs were analyzed before and after the surgical procedure. Before the 
surgical procedure, the OHIP-14 scores amounted to 5.6 (VCMX) and 5.2 (SCTG). These 
values increased due to the surgical procedure (soft tissue grafting) to 6.1 (VCMX) and 7.6 
(SCTG), demonstrating increased patient morbidity for the autogenous graft. Once final 
reconstructions were inserted, a new baseline examination took place. At that time-point and 
all subsequent follow-up time-points, OHIP-14 scores were calculated revealing values close 
to 0 at all time-points. It has previously been reported that OHIP scores assessed long after 
a successful therapy tend to reach values similar to the ones of healthy subject without any 
need of a therapy (John et al., 2004), thereby revealing an increased patient satisfaction. 
Interestingly at 3 years, the median OHIP score in group VCMX was significantly higher 
compared to all previous follow-up time-points and group SCTG. This was surprising since 
the tissues in the patient (responsible for the high values) were healthy and no biological, 
technical or esthetic problems had occurred. The respective patient, however, reported that 
the scores were due to personal issues and not related to the treatment. 
Conclusions
Three years after insertion of final reconstructions, the comparison between VCMX and the 
gold standard (SCTG) demonstrated negligible differences and stable outcomes in terms of 
the buccal tissue contour, marginal bone levels and esthetics. Peri-implant tissue remained 
healthy throughout the study period. The mucosal thickness slightly increased in both groups 
and PROMs reached values similar to the ones of healthy subjects. 
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Table and figure legends
Table 1: Patient demographics and p-values. SD = standard deviation; Q1 = first quartile; 
Q3 = third quartile; VCMX = volume-stable collagen matrix; SCTG = subepithelial connective 
tissue grafts; 1Mann-Whitney-U test
Table 2: Soft tissue thickness and p-values and change in soft tissue thickness and p-values. 
SD = standard deviation; Q1 = first quartile; Q3 = third quartile; VCMX = volume-stable 
collagen matrix; SCTG = subepithelial connective tissue graft; BL = baseline; 6M = follow-up 
at 6 months; FU-1 = follow-up at 1 year; FU-3 = follow-up at 3 years; MWU-test = Mann-
Whitney-U test; 1non-parametric Wilcoxon test (changes vs. visit baseline); 2Mann-Whitney-
U test; 3Hodges-Lehmann estimate of the treatment-related difference including 95% 
confidence interval (CI).
Table 3: Profilometric changes and p-values. SD = standard deviation; Q1 = first quartile; 
Q3 = third quartile; VCMX = volume-stable collagen matrix; SCTG = subepithelial connective 
tissue graft; BL = baseline; 6M = follow-up at 6 months; FU-1 = follow-up at 1 year; FU-3 = 
follow-up at 3 years; 1non-parametric Wilcoxon test; 2Mann-Whitney-U test; 3Hodges-
Lehmann estimate of the treatment-related difference including 95% confidence interval 
(CI).
Table 4: Marginal bone levels at different time-points and p-values. SD = standard deviation; 
Q1 = first quartile; Q3 = third quartile; VCMX = volume-stable collagen matrix; SCTG = 
subepithelial connective tissue graft; BL = baseline; FU-3 = follow-up at 3 years; 1non-
parametric Wilcoxon test; 2Mann-Whitney-U test;
Figure 1A: A case of the VCMX–group: A) Clinical situation at baseline of the implant-born 
reconstruction in position 21 B) Clinical situation at the 1-year follow-up C) Clinical situation 
at 3-year follow-up D) Cross-section through superimposed STL-files. Yellow line = baseline 
STL. Green Line = follow-up at 1-year STL. Red Line = follow-up at 3-year STL. E) View on 
3-dimensional STL file at FU-3 with ROI. ROI = region of interest; STL = standard 
tessellation language; VCMX = volume-stable collagen matrix; SCTG = subepithelial 
connective tissue graft; MG = margo mucosae.
Figure 1B: A case of the SCTG–group: A) Clinical situation at baseline of the implant born 
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follow-up D) Cross-section through superimposed STL-files. Yellow line = baseline STL. 
Green Line = follow-up at 1-year STL. Red Line = follow-up at 3-year STL. E) View on 3-
dimensional STL file at FU-3 with ROI. ROI = region of interest; STL = standard tessellation 
language; VCMX = volume-stable collagen matrix; SCTG = subepithelial connective tissue 
graft; MG = margo mucosae.
Figure 2: Consort flow-chart of study interventions. VCMX = volume-stable collagen matrix; 
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Appendix legends
Appendix Table 1. 
A. Bleeding on probing and p-values and change of bleeding on probing and p-values.
SD = standard deviation; Q1 = first quartile; Q3 = third quartile; VCMX = volume-stable 
collagen matrix; SCTG = subepithelial connective tissue graft; BL = baseline; 6M = follow-up 
at 6 months; FU-1 = follow-up at 1 year; FU-3 = follow-up at 3 years.
B. Plaque index and p-values (MWU-test) and change of plaque index and p-values. 
SD = standard deviation; Q1 = first quartile; Q3 = third quartile; VCMX = volume-stable 
collagen matrix; SCTG = subepithelial connective tissue graft; BL = baseline; 6M = follow-up 
at 6 months; FU-1 = follow-up at 1 year; FU-3 = follow-up at 3 years; 1non-parametric 
Wilcoxon test; 2Mann-Whitney-U test.
C. Probing depth and p-values (MWU-test) and change of probing depth and p-values. 
SD = standard deviation; Q1 = first quartile; Q3 = third quartile; VCMX = volume-stable 
collagen matrix; SCTG = subepithelial connective tissue graft; BL = baseline; 6M = follow-up 
at 6 months; FU-1 = follow-up at 1 year; FU-3 = follow-up at 3 years; 1non-parametric 
Wilcoxon test; 2Mann-Whitney-U test.
D. Width of keratinized tissue and p-values and change of width of keratinized tissue and p-
values. 
SD = standard deviation; Q1 = first quartile; Q3 = third quartile; VCMX = volume-stable 
collagen matrix; SCTG = subepithelial connective tissue graft; BL = baseline; 6M = follow-up 
at 6 months; FU-1 = follow-up at 1 year; FU-3 = follow-up at 3 years; 1non-parametric 
Wilcoxon test; 2Mann-Whitney-U test.
Appendix Table 2. Pink esthetic score and p-values and change of pink esthetic score and p-
values. SD = standard deviation; Q1 = first quartile; Q3 = third quartile; VCMX = volume-
stable collagen matrix; SCTG = subepithelial connective tissue graft; BL = baseline; 6M = 
follow-up at 6 months; FU-1 = follow-up at 1 year; FU-3 = follow-up at 3 years; 1non-
parametric Wilcoxon test; 2Mann-Whitney-U test.
Appendix Table 3. OHIP-G14 score and p-values. SD = standard deviation; Q1 = first 










connective tissue graft; BL = baseline; 6M = follow-up at 6 months; FU-1 = follow-up at 1 
year; FU-3 = follow-up at 3 years; 1Mann-Whitney-U test.
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Table 1  
 
  VCMX 
 
SCTG p-value1 
Gender n (female) 7 6 p = 1.000 
n (male) 3 4  
Age Mean ± SD 44.1 ± 12.8 43.4 ± 18.7 p = 1.000 
 
 
Median 46.0 47.5 




Mean ± SD  0.0 ± 0.0 1.0 ± 2.5 p = 0.184 
Median 0.0 0.0 
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Table 2  
 
  VCMX [mm] SCTG [mm] p-value2 
BL 
n 9 10 p = 0.128 
Mean ± SD 3.2 ± 0.8 2.7 ± 0.4 
Median 3.0 3.0 
Q1;Q3 3.0;4.0 2.5;3.0 
6M 
N 8 10 p = 1.000 
Mean ± SD 2.9 ± 0.9 3.0 ± 0.9 
Median 3.0 3.0 
Q1;Q3 2.0;3.8 2.0;3.5 
FU-1 
n 9 10 p = 0.900 
Mean ± SD 2.8 ± 0.7 3.1 ± 1.3 
Median 3.0 2.8 
Q1;Q3 2.0;3.0 2.0;4.0 
FU-3 
n 
Mean ± SD 
Median 
Q1;Q3 
Diff. [95% − 𝐶𝑙]3 
9 




3.8 ± 1.5 
3.3 
3.0;5.5 
p = 0.901 
 
0.0 [-1.5;1.0] 
BL to 6M 
n 8 10 p = 0.318 
Mean ± SD -0.3 ± 0.9 0.3 ± 1.0 







BL to FU-1 
n 8 10 p = 0.243 
Mean ± SD -0.4 ± 0.9 0.4 ± 1.4 









n 8 10 p = 0.303 
Mean ± SD 0.44 ± 1.1 1.1 ± 1.5 
Median 0.5 0.8 
Q1;Q3 -0.5;1.25 0.0;2.5 
p1 
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Table 3  
 
  VCMX [mm] SCTG [mm] p-value2 
BL to 6M 
n 9 10 p = 0.462 
Mean ± SD -0.1 ± 0.4 -0.2 ± 0.3 







BL to FU-1 
n 9 10 p = 0.369 
Mean ± SD -0.2 ± 0.5 -0.2 ± 0.2 







BL to FU-3 
n 8 9 p = 0.596 
Mean ± SD -0.3 ± 0.4 -0.2 ± 0.3 
Median -0.2  -0.1 
Q1;Q3 -0.5;-0.1 -0.8;0.1 
p1 0.039 0.020 
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Table 4  
 
  VCMX [mm] SCTG [mm] p-value2 
BL 
n 8 9 p = 0.006 
Mean ± SD 0.4 ± 0.5 -0.1 ± 0.3 
Median 0.3 -0.1 
Q1;Q3 0.3;0.6 -0.4; 0.2 
FU-3 
n 8 9 p = 0.736 
Mean ± SD -0.5 ± 1.0 -0.4 ± 0.3 
Median -0.4 -0.4 
Q1;Q3 0.5; 0.0 -0.6; -0.3 
BL to FU-3 
n 8 9 p = 0.163 
Mean ± SD -0.9 ± 1.0 -0.3 ± 0.3 
Median -0.7 -0.2 



































Assessed or eligibility (n = 20) 
Clinical measurement, basic periodontal 
parameters and impression taking 
Allocation 
Suture	removal 
 (7-10 days)  
Day of surgery 
Soft tissue thickness 
PROMs 
Randomization (n = 20) 
Abutment connection (3 month) 
 
Allocated to VCMX intervention (n = 10) Allocated to SCTG intervention (n = 10) 
Lost to follow-up (n = 0) Lost to follow-up (n = 0) 
Final restoration and Baseline (BL) 
 
Follow-up 6 months (6M) 
 
Follow-up 12 months (FU-1) 
 
Follow-up 36 months (FU-3)	
Lost to follow-up (n = 0) Lost to follow-up (n = 0) 
Lost to follow-up (n = 0) Lost to follow-up (n = 0) 
Lost to follow-up (emigration) (n = 1) 
Lost to follow-up (deceased) (n = 1) 
Lost to follow-up (n = 0) 
Lost to follow-up (n = 0) 
Lost to follow-up (deceased) (n = 1) 
Lost to follow-up (emigration) (n = 1) 
Lost to follow-up (emigration) (n = 1) 
jcpe_13271_f2.pdf
A
cc
ep
te
d
 A
rt
ic
le
